Cefixime Powder, For Suspension
Product Images NDC 65862-751

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefixime (NDC 65862-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))

Label for Cefixime oral suspension powder, USP 100 mg/5 mL by Aurobindo Pharma Limited. The 50 mL bottle, when reconstituted, contains cefixime trihydrate equivalent to 100 mg cefixime per 5 mL. Directions for reconstitution, storage, and usage instructions are provided, along with distributor and manufacturing information. The label includes a barcode and placeholders for coding/printing.*

FDA Label Image

Package Label-principal Display Panel (200 mg/5 mL (50 mL Bottle))

Cefixime for Oral Suspension, USP 200 mg/5 mL powder for suspension in a 50 mL bottle by Aurobindo Pharma Limited. The label includes reconstitution instructions with 35 mL water, dosage form and strength, usage directions, storage guidelines, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Cefixime Str)

Chemical structure of cefixime, the active ingredient in the drug product Cefixime. The diagram shows the molecular arrangement with labels for atoms and functional groups, including a beta-lactam ring and other characteristic features of cefixime's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.